NASDAQ · VVOS
Vivos Therapeutics, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for VVOS: Nov 18, 2026
Vivos Therapeutics, Inc. Common Stock is estimated to report earnings on 11/18/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.3. The reported EPS for the same quarter last year was $-0.49.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.30 | $-0.30 | $-0.30 | 1 |
| Dec 2026 | $-0.20 | $-0.20 | $-0.20 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Fintel · RTTNews · Zacks- Fintel · Oct 21, 4:37 PM EDTVivos Therapeutics, Inc. Regains Compliance with Nasdaq Stockholders' Equity StandardVivos Therapeutics, Inc. announced that on October 20, 2026, it received a letter from the Listing Qualifications staff of The Nasdaq Stock Market LLC stating that the company complies with the minimum stockholders' equity requirement of Nasdaq Listing Rule 5550(b)(1). This rule
- RTTNews · Oct 15, 11:32 AM EDTVivos Therapeutics Strikes $12M Stock Deal For SOD Sciences Stake And Test Rights(RTTNews) – On Thursday, Vivos Therapeutics, Inc. (VVOS), a medical device and healthcare services company focused on obstructive sleep apnea (OSA) and sleep-related breathing disorders, announced a definitive agreement to acquire an 11% fully diluted equity interest in SOD Scien
- RTTNews · Sep 9, 9:57 AM EDTVivos Therapeutics Exchanges $2.86 Million Of Debt For Shares; Stock Down(RTTNews) – Vivos Therapeutics, Inc. (VVOS), a medical device and healthcare services company, announced that on August 31, 2026, Vivos entered into twelve exchange agreements with Streeterville Capital, LLC, exchanging $2.86 million of outstanding principal under its secured pro
- RTTNews · Aug 28, 10:24 AM EDTVivos Therapeutics Advances South Florida Sleep Center With South Palm Cardiovascular Partnership(RTTNews) – Vivos Therapeutics, Inc. (VVOS), a medical device and healthcare services company focused on obstructive sleep apnea and breathing disorders, announced definitive collaboration and operating agreements with South Palm Cardiovascular Associates (SPCVA) to establish a r
- RTTNews · Aug 20, 10:46 AM EDTVivos Therapeutics Boosts Nevada Capacity With New $10M Revenue-Target Facility(RTTNews) – Vivos Therapeutics, Inc. (VVOS), a medical device and healthcare services company focused on sleep apnea and sleep disorders, announced the opening of a new diagnostic, testing and treatment facility in Henderson, Nevada.
- Zacks · Aug 14, 5:40 PM EDTVivos Therapeutics, Inc. (VVOS) Reports Q2 Loss, Lags Revenue EstimatesVivos Therapeutics (VVOS) delivered earnings and revenue surprises of +26.19% and -5.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 13, 8:50 AM EDTKaryopharm Therapeutics (KPTI) Reports Q2 Loss, Beats Revenue EstimatesKaryopharm Therapeutics (KPTI) delivered earnings and revenue surprises of -51.63% and +5.70%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Aug 11, 11:24 AM EDTVivos Therapeutics Expands Greenway AI Partnership, Targets $9.1M In Annual Value Creation; Stock Up(RTTNews) – Vivos Therapeutics Inc. (VVOS), a medical device and healthcare services company focused on obstructive sleep apnea and other sleep-related breathing disorders, has announced an expanded strategic partnership with Greenway Health.
- Zacks · Aug 6, 8:20 AM EDTZoetis (ZTS) Surpasses Q2 Earnings EstimatesZoetis (ZTS) delivered earnings and revenue surprises of +1.63% and -0.95%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Jun 10, 10:31 AM EDTVivos, SPCVA Form AIM Florida To Expand Sleep Apnea And Insomnia Care For CVD Patients(RTTNews) – Vivos Therapeutics, Inc. (VVOS), a medical device and healthcare services company focused on breathing-related sleep disorders, has entered into a collaboration agreement with South Palm Cardiovascular Associates, LLC (SPCVA), a multi-location cardiology practice with
- Zacks · May 15, 5:20 PM EDTPlus Therapeutics (PSTV) Reports Q1 Loss, Tops Revenue EstimatesPlus (PSTV) delivered earnings and revenue surprises of -11.11% and +8.21%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Apr 15, 10:07 PM EDTVivos Therapeutics Inc Full Year Sales Increase(RTTNews) – Vivos Therapeutics Inc (VVOS) released Loss for full year of -$21.17 million
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Vivos Therapeutics, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.